Copyright
©The Author(s) 2019.
World J Crit Care Med. Jun 12, 2019; 8(3): 18-27
Published online Jun 12, 2019. doi: 10.5492/wjccm.v8.i3.18
Published online Jun 12, 2019. doi: 10.5492/wjccm.v8.i3.18
Delirium subtypes | Notes |
Hypoactive (24.5%-43.5%)[6]: Apathy, decreased responsiveness, slowed motor function, withdrawn attitude, lethargy, and drowsiness | Poor response to antipsychotics |
Hyperactive (1.6%-23%)[6]: Agitation, hallucinations, restlessness | May respond to antipsychotics |
Mixed (52.5%)[6]: Fluctuation of hypoactive and hyperactive features | Requires a careful assessment over the time |
Prevention (Drugs) | |
Haloperidol | Poor efficacy on ICU-D prevention and related clinical outcomes (e.g., mortality). Not recommended[15] |
Atypical antipsychotics | Poor efficacy. Not recommended[15] |
Dexmedetomidine | Although not recommended[15], low doses (e.g., 0.1 μg/kg per hour) may reduce ICU-D occurrence |
Treatment (Drugs) | |
Haloperidol | Useful: 2-10 mg (IV every 6 h), but recommended for not routinely using (especially in hyperactive form)[15] |
Atypical antipsychotics | Olanzapine (IM 5-10 mg; max: 30 mg/d), risperidone (0.5-8 mg), quetiapine (orally 50 mg; max 400 mg/d), and ziprasidone (IM 10 mg; max: 40 mg/d)1. Starting regimens may need to be higher than maintenance doses; Recommended for not routinely using[15] |
Dexmedetomidine | Useful, but recommended (with low quality evidence) in adults under MV, especially when hyperactive manifestations preclude weaning[15] |
Short-acting benzodiazepines | Useful in patient experiencing alcohol or sedative withdrawal, or for delirium resulting from seizures; Lorazepam: IM and IV forms; no active metabolites (preferred); Midazolam: IM and IV forms; has active metabolites |
Drug side effects | |
Haloperidol | Insomnia, EPSs2 and agitation are the most common side effects. Dose dependent changes of EPSs. Cardiotoxicity occurs at doses > 2 mg IV |
Atypical antipsychotics | EPSs at high doses. Olanzapine and quetiapine may lead to excessive sedation, ziprasidone is more associated with QTc prolongation |
Dexmedetomidine | Bradycardia, and hypotension. Hypertension |
Benzodiazepines | Delirogenic effect |
- Citation: Cascella M, Fiore M, Leone S, Carbone D, Di Napoli R. Current controversies and future perspectives on treatment of intensive care unit delirium in adults. World J Crit Care Med 2019; 8(3): 18-27
- URL: https://www.wjgnet.com/2220-3141/full/v8/i3/18.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v8.i3.18